Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Small Cell Lung Carcinoma 9Burkitt Lymphoma 7Lung Neoplasms 6Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Sarcoma, Ewing 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Plasmablastic Lymphoma 3Multiple Myeloma 3Lymphoma 3Leukemia 3Hodgkin Disease 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Myelodysplastic Syndromes 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Immunoblastic Lymphadenopathy 2HIV Infections 2Ganglioneuroblastoma 2Congenital Abnormalities 2Blast Crisis 2Anemia, Refractory, with Excess of Blasts 2Wilms Tumor 1

Interventions

X-Rays 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Cyclophosphamide 2tazemetostat 1talazoparib 1palbociclib 1olaparib 1irinotecan sucrosofate 1fludarabine phosphate 1fludarabine 1Vincristine 1Vinblastine 1Vemurafenib 1Topotecan 1Temozolomide 1Pharmacogenomic Variants 1Methotrexate 1Mesna 1LY3023414 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Etoposide × 30 days × Clear all
NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
293 enrolled 89 charts
CNS

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡